VIVA BIOTECH HOLDINGS / PORDA HAVAS
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Portfolio Highlights: Clinical and Financial Updates of ABM, F5, AceLink, HAYA, Regenacy, and Arthrosi 2022-09-28 18:31
Viva Biotech Announced 2022 Interim Results 2022-08-29 23:55
Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis 2022-07-27 21:30
1 2